Thread by @ChrisRandone, What popping? New DD & locked in. This time we're focusing on [...]

What popping? New DD & locked in. This time we're focusing on $CHFS with how recent PR, future PR, projected revenue & a voted no against reverse split makes this stock even more on the radar than before.

(Thread Below)

First, always remember, this is my opinion based upon my research. This is deep DD, public information, not financial advice so make sure you always research before investing. This is a simple breakdown from my mindset & how I feel towards all this information...

So, CHF Solutions ($CHFS) makes a FDA-approved device called Aquadex that filter excess fluid out of your bloodstream. The condition of fluid overload can be seen in patients with heart failure. Most of the symptoms of CHF result from the extracellular fluid volume..

Fluid overload, also known as hypervolemia, is a condition in which there is too much fluid in the blood and generally refers to the expansion of the extracellular fluid volume. Although the body does need some amount of fluid to remain healthy...

too much can cause an imbalance and damage to an individual’s health. Congestive heart failure is the leading cause of fluid overload and is our primary disease target, representing approximately 75% of the total U.S. fluid management market...

$CHFS process of Ultrafiltration also can restore the body’s responsiveness to diuretic drugs and can result in more effective decongestion and fewer heart failure events, compared with diuretics. This is already a huge issue amongst patients struggling with Kidney failure but..

fluid and inflammatory cells build up in the lungs that prevents oxygen from getting through has been seen in an increase rate lately among COVID-19 patients. COVID-19 causes fluid imbalances in your body that are difficult to manage...

Fluid build up can attack many organs, the lungs, the heart, kidneys, liver, etc. A issue where excessive fluid puts a strain on those organs that leads to a great concern for the patient...

The condition of fluid overload can be seen in patients with heart failure. Most of the symptoms of congestive heart failure result from the extracellular fluid volume; for this reason, diuretics have been the cornerstone of heart failure treatment..

So, the Aquadex Smartflow System is being used to remove excess fluid from patients being treated with fluid resuscitation as part of the treatment for COVID-19 & in some cases is helping to relieve the shortage of dialysis machines at a growing number of hospitals..

The machine sells for under $35K & the single use disposable which is a blood filtration set is $900 & it's requires for each treatment session. Research shows the hospital-grade dialysis machine on average is around $80K...

This is a huge benefit for hospitals because a hospital could save about $4,000 per admission using Aquadex, compared with diuretics, over a 3 month period & $CHFS captures recurring revenue from the sale of single-use disposables for each Aquadex SmartFlow treatment session...

Also, these days many front lines and ICU doctors realizing that 30% to 40% of their most severely ill patients are developing acute kidney injury, and has been sounding the alarm that a life-saving fluid management devices are in short supply and high demand...

But most importantly, can help patients with severe overflow of fluid build up & help with acute kidney injuries. Also, helps allow for a 4:1 nurse to patient ratio, whereas the ratio with dialysis machines is 1:1...

So now that we understand $CHFS & their Aquadex console, let's look at potential projected numbers with revenue. In April, $CHFS increased over 300% compared to the monthly-average for 2019 & that was just the beginning of COVID-19...

The Chimera Research Group did an example of a hospital like Mount-Sinai. They have 13 devices, if you calculate only one patient per device, that’s 13 filters a day, so for a full month that is around $380K revenue from one hospital...

So if you made that same calculation for for the 250 devices in the United States, that is about $7.3M a month worth of filters (just filters), let's not forget the $31,000 per machine ($7.75 Million for every 250 machines)...

There's already machines in Europe & over 100+ machines globally with Italy being their biggest customer & now, Brazil just two days ago made a large purchase of Aquadex consoles due to the rapid growth of cases there...

http://www.in.gov.br/en/web/dou/-/resolucao-re-n-2.598-de-22-de-julho-de-2020-268193898

Aside from this, the BIGGEST play in this entire situation is the VOTED NO for reverse split. $CHFS is in a situation where they need to gain compliance & the shareholders voted NO against a reverse split which tells me one thing, they feel they can gain compliance organically...

What does that mean for us potentially? Well, organically means PR in some fashion (revenue, merger, buy out, acquisition, COVID-19 news, etc..). A huge bonus for us because currently they are trading at .80/share & if organically is the way to go, the gamble is...

Believing they have what it takes to raise the share price organically which based on their recent news of how many hospitals they are in & Brazil sales, could be the momentum that begins the move.

Now, I don't know what to expect but it at leasts helps us understand $CHFS a little more now. I'll also share a few links down below to help you understand Fluid build up, how it works in COVID patients & more on $CHFS, have a great Saturday night...

Some sites:

https://www.cleveland.com/coronavirus/2020/03/coronavirus-and-the-lungs-does-covid-19-cause-more-severe-pneumonia-or-ards-than-other-viruses.html

https://www.sciencealert.com/heart-scans-are-better-for-covid-19-patient-treatment-says-study

https://www.politico.com/news/2020/04/15/dialysis-kidney-coronavirus-188840

https://www.livescience.com/silent-hypoxia-killing-covid-19-coronavirus-patients.html

https://www.chf-solutions.com/aquadex-smartflow-system/ordering-information/

Coronavirus and the lungs: Does COVID-19 cause more severe pneumonia or ARDS than other viruses?

The coronavirus may turn out to be distinct in certain ways, but the fundamental way it presents in the lungs is similar to other viruses, experts said.

https://www.cleveland.com/coronavirus/2020/03/coronavirus-and-the-lungs-does-covid-19-cause-more-severe-pneumonia-or-ards-than-other-viruses.html

Latest Threads Unrolled: